Literature DB >> 8423034

Experimental hepatitis induced by ethanol after immunization with acetaldehyde adducts.

H Yokoyama1, H Ishii, S Nagata, S Kato, K Kamegaya, M Tsuchiya.   

Abstract

We produced hepatitis in guinea pigs by immunization with acetaldehyde adducts and ethanol treatment. Human hemoglobin-acetaldehyde adducts were prepared without any reducing agents and affinity purified with polyclonal antibodies against acetaldehyde adducts. Female guinea pigs were immunized with the adducts and were simultaneously given ethanol for 40 days. These treatments induced hepatic necrosis with infiltration of mononuclear cells in the hepatic lobules. The formation of the lymphoid follicle was also observed in severe cases. These changes were accompanied by the elevation of serum AST and lactic dehydrogenase activities and titers of circulating antibodies against acetaldehyde adducts. By contrast, the combination of ethanol and immunization with unmodified hemoglobin produced only fatty change of the liver, and animals immunized with the adducts alone had minimal inflammatory changes of the liver. Peripheral blood lymphocytes obtained from the animals with hepatitis were shown to be stimulated by acetaldehyde adducts to a significantly greater degree than those from control animals who received nothing, ethanol alone or ethanol and unmodified hemoglobin. These results suggest that the immune response to acetaldehyde adducts may be involved, at least partly, in the pathogenesis of inflammation observed in alcoholic liver disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8423034

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  8 in total

Review 1.  Clinical and pathological features of alcohol-related brain damage.

Authors:  Natalie M Zahr; Kimberley L Kaufman; Clive G Harper
Journal:  Nat Rev Neurol       Date:  2011-04-12       Impact factor: 42.937

2.  Differential immune responses to albumin adducts of reactive intermediates of trichloroethene in MRL+/+ mice.

Authors:  Ping Cai; Rolf König; M Firoze Khan; Bhupendra S Kaphalia; G A S Ansari
Journal:  Toxicol Appl Pharmacol       Date:  2007-02-08       Impact factor: 4.219

3.  Autoantibody against a 78 kDa membrane protein of HepG2 cell in the sera of patients with alcoholic liver diseases.

Authors:  T Numata; J Kato; Y Kohgo; S Katsuki; H Kondo; Y Niitsu
Journal:  J Gastroenterol       Date:  1995-12       Impact factor: 7.527

4.  Liver tissue metabolically transformed by alcohol induces immune recognition of liver self-proteins but not in vivo inflammation.

Authors:  Michael J Duryee; Benjamin M Wiese; Jordan R Bowman; Jared D Vanlandingham; Lynell W Klassen; Geoffrey E Thiele; Carlos D Hunter; Daniel R Anderson; Ted R Mikuls; Geoffrey M Thiele
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-12-28       Impact factor: 4.052

Review 5.  "Second hit" models of alcoholic liver disease.

Authors:  Hidekazu Tsukamoto; Keigo Machida; Alla Dynnyk; Hasmik Mkrtchyan
Journal:  Semin Liver Dis       Date:  2009-04-22       Impact factor: 6.115

6.  Immune mechanisms in alcoholic liver disease.

Authors:  Emanuele Albano; Matteo Vidali
Journal:  Genes Nutr       Date:  2009-10-07       Impact factor: 5.523

Review 7.  Acetaldehyde adducts in alcoholic liver disease.

Authors:  Mashiko Setshedi; Jack R Wands; Suzanne M de la Monte
Journal:  Oxid Med Cell Longev       Date:  2010 May-Jun       Impact factor: 6.543

8.  Role of adaptive immunity in alcoholic liver disease.

Authors:  Emanuele Albano
Journal:  Int J Hepatol       Date:  2011-09-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.